Ignite Creation Date:
2025-12-25 @ 5:19 AM
Ignite Modification Date:
2025-12-26 @ 4:27 AM
Study NCT ID:
NCT01364727
Status:
COMPLETED
Last Update Posted:
2019-04-16
First Post:
2011-05-31
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Phase 2 Study of Amrubicin in Relapsed or Refractory Thymic Malignancies
Sponsor:
Heather Wakelee
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-06
Start Date Type:
ACTUAL
Primary Completion Date:
2014-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-12-31
Completion Date Type:
ACTUAL
First Submit Date:
2011-05-31
First Submit QC Date:
None
Study First Post Date:
2011-06-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-01-23
Results First Submit QC Date:
None
Results First Post Date:
2017-03-14
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-04-05
Last Update Post Date:
2019-04-16
Last Update Post Date Type:
ACTUAL